164 related articles for article (PubMed ID: 37895928)
1. Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening.
Yao C; Shen Z; Shen L; Kadier K; Zhao J; Guo Y; Xu L; Cao J; Dong X; Yang B
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895928
[TBL] [Abstract][Full Text] [Related]
2. Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay.
Rajan RK; Ramanathan M
J Comput Aided Mol Des; 2020 Jun; 34(6):671-682. PubMed ID: 32040807
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer's disease.
Devi B; Jangid K; Kumar N; Kumar V; Kumar V
Mol Divers; 2024 Apr; ():. PubMed ID: 38573427
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potential WEE1 inhibitors via hybrid virtual screening.
Jin T; Xu W; Chen R; Shen L; Gao J; Xu L; Chi X; Lin N; Zhou L; Shen Z; Zhang B
Front Pharmacol; 2023; 14():1298245. PubMed ID: 38143493
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease.
Shuai W; Bu F; Zhu Y; Wu Y; Xiao H; Pan X; Zhang J; Sun Q; Wang G; Ouyang L
J Med Chem; 2023 Jan; 66(2):1273-1300. PubMed ID: 36649216
[TBL] [Abstract][Full Text] [Related]
6. Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.
Zulfiqar Z; Shah FA; Shafique S; Alattar A; Ali T; Alvi AM; Rashid S; Li S
J Inflamm Res; 2020; 13():1185-1205. PubMed ID: 33384558
[TBL] [Abstract][Full Text] [Related]
7. Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases.
Jun J; Baek J; Kang D; Moon H; Kim H; Cho H; Hah JM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114917. PubMed ID: 36395646
[TBL] [Abstract][Full Text] [Related]
8. Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
Fricker M; Lograsso P; Ellis S; Wilkie N; Hunt P; Pollack SJ
Arch Biochem Biophys; 2005 Jun; 438(2):195-205. PubMed ID: 15907786
[TBL] [Abstract][Full Text] [Related]
9. A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3.
Wei J; Pan Y; Shen Z; Shen L; Xu L; Yu W; Huang W
Front Med (Lausanne); 2023; 10():1182227. PubMed ID: 37886358
[TBL] [Abstract][Full Text] [Related]
10. Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.
Chen X; Zhao J; Chen R; Shen L; Lu J; Guo Y; Chi X; Geng S; Zhang Q; Pan Z; He X; Xu L; Shen Z; Yang H; Lei T
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300516. PubMed ID: 38263717
[TBL] [Abstract][Full Text] [Related]
11. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
Chahal V; Kakkar R
J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
[TBL] [Abstract][Full Text] [Related]
12. JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties.
Wu Y; Zhao Y; Guan Z; Esmaeili S; Xiao Z; Kuriakose D
Cell Adh Migr; 2024 Dec; 18(1):1-11. PubMed ID: 38357988
[TBL] [Abstract][Full Text] [Related]
13. A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking Studies.
Cho H; Hah JM
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680547
[TBL] [Abstract][Full Text] [Related]
14. Exploring natural compound, Panicutine as leucine-rich repeat kinase 2 inhibitor against Parkinson's disease: a structure-guided approach.
Majrashi TA; Wahab S; Almoyad MAA; Alkhathami AG; Alshahrani MY
J Biomol Struct Dyn; 2023 Oct; ():1-10. PubMed ID: 37837424
[TBL] [Abstract][Full Text] [Related]
15. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors.
Di Stefano M; Galati S; Ortore G; Caligiuri I; Rizzolio F; Ceni C; Bertini S; Bononi G; Granchi C; Macchia M; Poli G; Tuccinardi T
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142566
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.
Tuffaha GO; Hatmal MM; Taha MO
J Mol Graph Model; 2019 Sep; 91():30-51. PubMed ID: 31158642
[TBL] [Abstract][Full Text] [Related]
18. Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors.
Duong MTH; Ahn HC
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145648
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
20. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
